The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
![Mabion-logo-granat-rgb](https://cebioforum.com/wp-content/uploads/2023/02/Mabion-logo-granat-rgb-e1677162996427.png)
Mabion is an innovative Polish biotechnology company specializing in the production and research of biologic drugs, including the development and manufacturing of modern vaccines. The Mabion team consists of experts in biotechnology, molecular biology, and chemistry, who are constantly working on innovative solutions in the field of medicine.
![nanogroup](https://cebioforum.com/wp-content/uploads/2022/11/nanogroup-e1680771312245.png)
NanoGroup is a company based in Warsaw, focused on developing innovative solutions in the field of nanotechnology. Their research focuses on the development of advanced materials and nanoscale technologies, with applications ranging from healthcare and energy to consumer electronics. NanoGroup is known for their expertise in the production of nanoparticles, including liposomes and metallic nanoparticles, as well as their ability to customize their products to meet specific customer needs.
![blirt1](https://cebioforum.com/wp-content/uploads/2022/11/blirt1-300x150.png)
Blirt is a biotechnology company based in Gdansk, specializing in research and development services for the life sciences industry. They offer a wide range of services, including gene synthesis, cloning, protein expression, and cell line development. Blirt also provides custom solutions for molecular biology and biotechnology research, helping their clients accelerate the discovery and development of new products. With a strong focus on quality and innovation, Blirt has become a trusted partner for many leading pharmaceutical and biotech companies.
![wpdpharmaceuticals](https://cebioforum.com/wp-content/uploads/2022/11/wpdpharmaceuticals.png)
WPD Pharmaceuticals is a biopharmaceutical company focused on the development of innovative cancer therapies. Based in Canada, WPD Pharmaceuticals has a pipeline of drug candidates targeting different types of cancers, including glioblastoma, pancreatic cancer, and leukemia. Company is also focused on repurposing existing drugs for new indications, such as using azithromycin to treat certain cancers. With a mission to improve patient outcomes, WPD Pharmaceuticals is committed to advancing their pipeline and bringing new treatments to the market.
![Print](https://cebioforum.com/wp-content/uploads/2022/11/CELON1-e1676299150927.jpg)
Celon Pharma is a company specializing in the research and development of innovative drugs for the treatment of cancer, Alzheimer’s disease, and other central nervous system disorders. The company’s pipeline includes several drug candidates, including small molecules and biologics, in various stages of development. Celon Pharma is also focused on developing drug delivery systems to improve the effectiveness and safety of their therapies. With a strong focus on innovation and quality, Celon Pharma is committed to bringing new therapies to patients in need, while also expanding its global presence through partnerships and collaborations with leading pharmaceutical companies.
![biogen1](https://cebioforum.com/wp-content/uploads/2022/11/biogen1.png)
BIO-GEN is a technology company specialising in research and production of biopreparations to support agriculture and the environment. The company was founded in 1990 and in 32 years of operation we have succeeded in establishing ourselves as one of the world’s leading manufacturers of microbiological preparations.
![FamiCord_TX](https://cebioforum.com/wp-content/uploads/2022/11/FamiCord_TX.jpg)
Famicord Tx is company that specializes in cord blood banking and stem cell research. The company offers umbilical cord blood and tissue banking services to families who wish to store their newborn’s stem cells for potential future medical use. Famicord is also involved in stem cell research and development, with a focus on regenerative medicine applications. The company’s state-of-the-art laboratories and highly trained personnel ensure the highest quality of service and care for their clients. With a strong commitment to research and innovation, Famicord is dedicated to advancing the field of stem cell technology and improving patient outcomes.
![syvento](https://cebioforum.com/wp-content/uploads/2023/03/syvento.png)
SyVento is an expert in active substance delivery systems for cosmetic products and dietary supplements. It offers a number of formulations supported by numerous in vitro and in vivo studies, which prove that the active substances enclosed in Vecticell and Lipoline carriers are characterized by much greater bioavailability, stability and effectiveness.
![logo cellivia_monserrat_ciemnozielone_png](https://cebioforum.com/wp-content/uploads/2022/11/logo-cellivia_monserrat_ciemnozielone_png.png)
Cellivia 3 S.A. is a company combining knowledge in the field of: biotechnology, medicine and robotics. The company deals with: material banking
from the area of the oral cavity, development of technology for the production of advanced therapy drugs, research in the field of cell and tissue bioengineering, biotechnology and biomedicine, as well as the application of bioengineering and robotics in the medical industry.
![agraplant](https://cebioforum.com/wp-content/uploads/2022/11/agraplant.png)
The mission of our company is to promote such innovations in agriculture that do not harm the environment and humans. They support natural processes and protect them. At every stage of our operation, we are guided by the principle that customer satisfaction is the most important. We believe that our knowledge will be useful, and the proposed solutions will solve many problems without undue interference in nature.
![GlobalPharma_logo](https://cebioforum.com/wp-content/uploads/2023/06/GlobalPharma_logo.png)
Since the end of 2021, GLOBAL PHARMA CM S.A. has been part of the NEUCA S.A. Group, which has been listed on the Warsaw Stock Exchange since 2004. We are an innovative Polish company from the pharmaceutical sector with 100% Polish capital. Our principal place of business is located in Suchedniów, Świętokrzyskie Province, Poland. We focus on conducting research and development (R&D) in the area of product concept development, conducting relevant research and testing, up to the final registration of new medical devices and dietary supplements and contract manufacturing of Class I and II medical devices and dietary supplements. We have two specialised production facilities, where we manufacture a dozen or so different production forms for customers from all over the world. We provide services to both large corporations and companies taking their first steps in the pharmaceutical industry. We have an extensive Research and Development Department ensuring the highest quality and innovation of services provided. We do not have our own brands – 100% of our focus is on contract services for our customers.